Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 5/20 | 0.54 |
| ▸ | CA2 | P00918 | 5/20 | 0.54 |
| ▸ | CA9 | Q16790 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA3 | P07451 | 3/20 | 0.54 |
| ▸ | CA4 | P22748 | 3/20 | 0.54 |
| ▸ | CA6 | P23280 | 3/20 | 0.54 |
| ▸ | CA5A | P35218 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 3/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1759744 | 0.91 | TDP1 (0.66) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL5314186 | 0.89 | BCHE (0.54) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| Biphenyl SCHEMBL3116344 | 0.87 | TDP1 (0.56) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL28864044 | 0.84 | ALDH1A1 (0.59) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL7850856 | 0.82 | ALDH1A1 (0.56) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL5165470 | 0.81 | TDP1 (0.59) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL9418416 | 0.81 | TDP1 (0.46) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL28864047 | 0.80 | ALDH1A1 (0.54) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL197599 | 0.80 | ALDH1A1 (0.54) | ALDH1A1CYP3A4MAPK1CA1CA2 | |
| SCHEMBL1985748 | 0.80 | ALDH1A1 (0.54) | ALDH1A1CYP3A4MAPK1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865932-B | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-117865932-A | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | 北京化工大学 | 2024-04-12 | — | — | CN | claimed |
| US-4115058-A | BLEACHES, DETERGENTS | FMC CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
| EP-2334640-B1 | METHODS FOR PRODUCING PARICALCITOL | AZAD PHARMACEUTICAL INGREDIENTS AG (CH) | 2015-12-23 | — | — | EP | disclosed |
| US-9212136-B2 | Methods for producing paricalcitol | AZAD PHARMACEUTICALS INGREDIENTS AG (CH) | 2015-12-15 | — | — | US | disclosed |
| EP-1274681-B1 | PROCESS FOR PRODUCING AMIDE COMPOUND | MITSUBISHI CHEM CORP (JP) | 2011-08-17 | — | — | EP | disclosed |
| US-20110184199-A1 | Methods For Producing Paricalcitol | AZAD PHARMA AG (CH) | 2011-07-28 | — | — | US | disclosed |
| EP-2334640-A2 | METHODS FOR PRODUCING PARICALCITOL | Azad Pharmaceutical Ingredients AG (CH) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010009879-A2 | METHODS FOR PRODUCING PARICALCITOL | AZAD PHARMACEUTICAL INGREDIENTS AG (CH) | 2010-01-28 | — | — | WO | disclosed |
| EP-1274681-A1 | PROCESS FOR PRODUCING AMIDE COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-6489474-B1 | A PROCESS FOR PRODUCING AN AMIDE COMPOUND BY SUBJECTING AN OXIME COMPOUND TO BECKMANN REARRANGEMENT IN A LIQUID PHASE, WHEREIN THE REACTION IS CARRIED OUT IN THE PRESENCE OF A NON-FLUORINE-CONTAINING SULFONIC ANHYDRIDE AND AN | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-12-03 | — | — | US | disclosed |
| WO-2001081302-A1 | PROCESS FOR PRODUCING AMIDE COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-11-01 | — | — | WO | disclosed |
| US-4689412-A | ANHYDRIDES OF SULFONIC ACIDS OR SULFURIC ACID HALF ESTERS, CATALYSTS | HULS AKTIENGESELLSCHAFT (DE) | 1987-08-25 | — | — | US | disclosed |
| US-4115058-A | BLEACHES, DETERGENTS | FMC CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184199-A1 | Methods For Producing Paricalcitol | CYP2R1, PTH1R, CYP24A1 | ALDH1A1 3875/4885CYP3A4 1025/4885MAPK1 4664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.